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URL: http://www.nber.org/chapters/c10348Mortality rates decline extremely rapidly in the United States over the
twentieth century, as they did in all developed countries. Figure 9.1 shows
the magnitude of the decline. In 1900, 1 in 42 Americans died annually. On
an age-adjusted basis, the share in 1998 was 1 in 125 people, for a cumula-
tive decline of 67 percent. Given such a substantial improvement in mor-
tality, it is natural to ask how we achieved such gains in health and which
innovations or policies contributed most to these gains.
Such a task is clearly large. One way to start is to analyze major trends
in mortality over the century and to consider how mortality declines diﬀer
by age and cause of death. By providing detailed information on which de-
mographic groups experienced the largest mortality improvements and for
what causes of death, these analyses motivate hypotheses to explain the
overall improvement in mortality in the twentieth century.
The mortality decline shown in ﬁgure 9.1 seems approximately linear
over the time period. Mortality decreased at a relatively constant rate of 1
percent per year between 1900 and 1940. There was then a period of rapid
decline from 1940 to 1955 in which mortality declined 2 percent per year,
followed by essentially ﬂat mortality rates until 1965. Since 1965, mortal-
ity rates have fallen at roughly 1 to 1.5 percent per year. This relative con-
stancy of mortality decline suggests that perhaps a single factor can
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.explain the trend in longer life; the popular Lee and Carter (1992) model
of mortality posits a driving force of mortality that is approximately con-
stant over time.
But the aggregate trends mask as much as they reveal. While mortality
declines have been relatively continuous over the twentieth century, the age
distribution of mortality decline has not. We start oﬀ the paper by high-
lighting a basic fact about mortality declines in the past century: Mortal-
ity reduction used to be concentrated at younger ages but is increasingly
concentrated among the aged. In the ﬁrst four decades of the century, 80
percent of life expectancy improvements resulted from reduced mortality
for those below age forty-ﬁve, with the bulk of this for infants and children.
In the next two decades, life expectancy improvements were split relatively
evenly by age. In the latter four decades, about two-thirds of life expec-
tancy improvements resulted from mortality reductions for those over age
forty-ﬁve; only one-third was from the younger population.
This change has been accompanied by several important epidemiologi-
cal trends. Throughout the ﬁrst half of the twentieth century, infectious
diseases were the leading cause of death. Changes in the ability to avoid
and withstand infection were the prime factors in reduced mortality in the
ﬁrst part of the century. This disease-ﬁghting ability was not predomi-
nantly medical. Nutrition (Fogel 1994) and public health measures (Pres-
ton 1996) were vastly more important in reduced mortality over this time
period than were medical interventions, as substantial research docu-
ments. Nutrition and public health were particularly important for the
young, and so mortality reduction was concentrated at younger ages.
Between 1940 and 1960, infectious diseases continue to decline, but was
due more to medical factors. Antibiotics, including penicillin and sulfa
drugs, became important contributors to mortality reduction in this era.
Antibiotics help the elderly as well as the young, and so mortality reduc-
tions became more widespread across the age distribution.
Since 1960, mortality reductions have been associated with two new fac-
tors: the conquest of cardiovascular disease in the elderly, and the preven-
tion of infant death due to low birth weight. While it is not entirely clear
what factors account for the reduction in cardiovascular disease mortality,
the traditional roles of nutrition, public health, and antibiotics are cer-
tainly less important. Taking their place are factors related to individual
behaviors, such as smoking and diet and high-tech medical treatment. We
term this change the “medicalization” of death: Increasingly, mortality re-
ductions are attributed to medical care and not social or environmental im-
provements.
The medicalization of death does not imply that medicine is the only fac-
tor inﬂuencing mortality. For several important causes of death, income
improvements and social programs have had and continue to have a large
Changes in the Age Distribution of Mortality 335impact on mortality. For example, Medicare likely has a direct impact on
mortality by increasing elderly access to medical care, but it also may have
important income eﬀects since it reduced out of pocket spending by the
elderly for medical care. Social Security and civil rights programs may also
be important in better health. We do not quantify the role of medicine, in-
come, social programs, and other factors in improved mortality in the last
half century, but we show examples where each is important as a ﬁrst step
in this research process.
The paper is structured as follows. The ﬁrst section presents the basic
facts about changes in the age distribution of mortality change and life ex-
pectancy improvements, highlighting the growing role of mortality reduc-
tions among the elderly. The next three sections examine why this trend has
occurred, discussing in particular the epidemiology of mortality reduction
at diﬀerent points in time and for diﬀerent causes. The ﬁfth section then
presents limited evidence on the nonmedical factors that inﬂuence mor-
tality.
9.1 Changes in the Age Distribution of Longer Life
We start the analysis by summarizing changes in the age distribution of
mortality improvements over time. One can summarize mortality rates in
many ways. We consider a relatively simple measure: life expectancy at
birth [LE0(t)]. This measure has the advantage that it weights mortality
changes by how important they are to overall survival. Mortality reduc-
tions in an age range where few people die will not contribute as much to
improvements in life expectancy at birth as mortality reductions in an age
range where there are more deaths.
Because it is helpful for our analysis, let us be more precise about the
measure. Consider a cohort of people born in year t. At age 0, the share of
people who die is p(0, t). Suppose the initial population had S(0, t) people.
The number of people alive at the end of year t and entering next year is
S(1, t   1)   S(0, t)   [1 – p(0, t)]. To forecast life expectancy, we need to
forecast the share of people who will die in year t   1, at age 1, and more
generally the share of people who will die at age a, in year t   a. Following
standard conventions, we use a period life table and assume that the prob-
ability of death at any age a in the future will be equal to the probability of
death of people aged a in year t, or p(a, t   a)   p(a, t). This estimate is
static; it assumes no change in mortality in the future. Although this is not
the best forecasting technique—mortality rates have fallen over time—it is
appropriate for our purposes of decomposing changes over time.
People who die at age a are assumed to have died halfway through the
year. Thus, life expectancy for a person dying at age a is a – 1/2. Adding
across all possible ages of death, up to maximum longevity T, life expec-
tancy at birth is then
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a 1
s 0
[1   p(s, t)],
and for simplicity, we assume that the cohort, S(0, t), equals 1.
Figure 9.2shows life expectancy at birth in the United States in the twen-
tieth century. In 1900, the average infant could expect to live forty-eight
years. By the end of the century, life expectancy was near eighty years.
We want to understand how changes in mortality at diﬀerent ages con-
tribute to overall life expectancy improvements. To do this, we compare t
with another year t . If we substitute t  for t in equations (1) and (2), equa-
tion (1) will give us life expectancy at birth in year t . But we can also sub-
stitute selectively. For example, suppose we replace p(a, t) with p(a, t ) just
for the elderly. We denote p (a, t) as the new mortality probability at any
age. Life expectancy at birth is then
(3) LE  0(t)  ∑
T
a 0





where S (a – 1, t) is deﬁned analogously to equation (2), substituting p (a,
t) for p(a, t). The diﬀerence between equations (3) and (1), LE  0(t) – LE0(t)
is the eﬀect of mortality changes between tand t on overall years of life ex-
pectancy at birth.
If we estimate equation (3), replacing diﬀerent age groups sequentially
and then add up the life expectancy improvements attributable to each age
group, the resulting improvement in life expectancy will be close to, but not
exactly the same as, the eﬀect of considering changes for all age groups to-
gether. The reason for the discrepancy has to do with the covariance of
beneﬁts from mortality reduction at diﬀerent ages. Saving more babies has
a greater impact on life expectancy at birth when the elderly also live longer
than when elderly mortality is assumed constant, because more people
reach their older years as infant mortality falls and thus beneﬁt from the
improvements in elderly mortality. We group the covariance eﬀects be-
tween mortality reductions in diﬀerent age groups into one term.
We estimate equations (1) through (3) empirically by considering mor-
tality changes for ﬁve groups in the population: infant mortality ( one);
child mortality (one–fourteen); young adult mortality (ﬁfteen–forty-four);
older adult mortality (forty-ﬁve–sixty-four); and elderly mortality (sixty-
ﬁve ). We consider the impact of mortality changes in each of these age
groups over three time periods: 1900–40; 1940–60; and 1960–90. The rea-
son for choosing these time periods will become apparent later. Thus, our
ﬁrst estimate is how much of the overall improvement in life expectancy at










































































.birth between 1900 and 1940 is a function of reduced mortality for each of
those ﬁve age groups and so on for the diﬀerent time periods.
Figure 9.3 and table 9.1 show the results. Throughout the paper, total
mortality estimates are age-adjusted to the 1990 population age distribu-
tion unless otherwise noted. Our results are not sensitive to our choice to
age-adjust based on the 1990 population. The ﬁrst bars of ﬁgure 9.3 and
column (1) of table 9.1 shows the contributors to life expectancy improve-
ments at birth in the 1900–40 time period; the second bars and column are
for the 1940–60 time period; and the third bars and column are for the
1960–90 time period. In the 1900–40 era, life expectancy improvements
were concentrated at younger ages. Reduced infant mortality, for example,
contributed 4 and a half years to overall improvements in life expectancy.
Reduced child mortality contributed nearly as much, and reduced young
adult mortality contributed about 3 and a half years. Together, these three
changes account for nearly thirteen of the sixteen-year increase in expected
longevity. Mortality reductions among older adults and the elderly, in
contrast, explain just 1 and a half years of increased longevity combined.
About 80 percent of longevity improvements, therefore, are attributable to
reduced mortality among the under-forty-ﬁve population.
The next bars of the ﬁgure and column of the table are for the two
decades in the middle of the century, 1940–60. The overall improvement in
life expectancy at birth is smaller in this time period than in the 1900–40
time period. The change between 1940 and 1960, for example, is 6.4 years,
compared to 15.9 years in the previous four decades. Part of the smaller im-
provement is due to the fact that the time interval is only half as large, but
that is not all of the explanation.
More important for our analysis, the contribution of mortality declines
at diﬀerent ages to overall improvements in life expectancy is very diﬀerent
from the earlier time period. In the 1940–60 time period, the diﬀerent age
groups all contributed roughly equally to improvements in life expectancy
at birth. The eﬀect of mortality reductions in each age group is about 1 to
1 and a half years of additional life. Only 60 percent of overall improve-
ments resulted from reduced mortality among the under-forty-ﬁve popu-
lation; 35 percent is from the older population.
The third bars and last column of the table show the results for the 1960–
90 time period. Once again, the situation changed greatly. Infant mortality
was still an important source of increased longevity in the latter three
decades, but child and young adult mortality were substantially less im-
portant. Taking their place were older adult and elderly mortality reduc-
tions. Reduced mortality among older adults and the elderly contributed
in total about three years to overall improvements in life expectancy at
birth. Changes in mortality for these age groups explain two-thirds of the
overall improvement in life expectancy at birth.

















































































.The greater relative contribution of mortality reductions for the older
population in the post-1960 period can be explained by two factors. The
ﬁrst is that mortality reductions for the elderly were more rapid in the later
time period than in the earlier one. Figure 9.4 and table 9.2 shows the an-
nual rate of decline in mortality for the diﬀerent population groups. Where
mortality among the elderly declined by only 0.3 percent per year between
1900 and 1940, mortality declined by 1.1 percent per year after 1960.
The second explanation is that overall mortality rates among the young
were already very low by 1960 so that even large continued increases in the
rateof decline translated into much smaller changes in the absolute levelof
mortality. Compared to 1900, mortality among infants was only 15 percent
as high in 1960. Even when mortality rates for infants continued to decline
at their pre-1960 level, as table 9.2 shows, the absolute changes correspon-
ding to these declines were much smaller. By 1960, 70 percent of infants
were already surviving to age sixty-ﬁve; this share could not increase that
rapidly in subsequent generations.1
For both of these reasons, the nature of longevity improvements shifted
over time. Where longevity improvements were concentrated at younger
ages early in the century, they were increasingly pronounced among the
elderly in the latter decades. Overall survival still increased, but the timing
of those changes was very diﬀerent.
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Table 9.1 Contributions to Life Expectancy at Birth
Change in Life Expectancy at Birth 1900–1940 1940–1960 1960–1990
Total change (%) 15.9 6.4 5.1
Change attributable to:
Infant mortality ( 1) 4.7 1.4 1.2
Child mortality (1–14) 4.4 0.7 0.3
Young adult mortality (15–44) 3.6 1.6 0.3
Older adult mortality (45–64) 1.0 1.1 1.4
Elderly mortality (65 ) 0.4 1.2 1.8
Covariance terms 1.8 0.4 0.1
Notes: The text describes the decomposition. Ages in parentheses.
1. This fact leads to a third potential explanation for the shift in longevity improvements
toward the elderly, but one that is not empirically so consequential. Since the probability that
an infant survived to older ages was greater in 1960 than in 1900, the same reduction in mor-
tality rates for the elderly would have a larger impact on life expectancy at birth in the later
time period. But the dominant factor in the increased contribution of mortality declines
among the elderly is the more rapid reduction in mortality rates for the elderly, not the in-












































































.9.2 The First Four Decades: Public Health and Nutrition
Our goal in the next several sections is to understand why longevity im-
provements have shifted towards the elderly. There are two ways to under-
stand this. The ﬁrst is at the epidemiological level—what factors about
mortality changed over the twentieth century that led to the shifting pat-
tern of mortality decline? The second level of understanding is at the eco-
nomic and social level—what is the underlying reason for the change in
those causes of death?
An example illustrates the diﬀerence. Since the late eighteenth century,
mortality rates have been declining in most developed countries. The cause
of this is reduced death from infectious disease. That is the basic epidemi-
ological fact. But the real issue is why infectious disease mortality declined.
Was it improved nutrition that allowed people to avoid and withstand in-
fections better, public health measures that reduced the spread of diseases,
or did diseases become less virulent? The latter questions are the subject of
substantial research in historical demography and are the ultimate object
of interest.
We do not answer the questions we ask at the detailed level. Indeed, it
has taken decades of work to distinguish between public health, nutri-
tional, and medical explanations for mortality reductions over the course
of the eighteenth and nineteenth centuries, so attempting such an analysis
here for the twentieth century would be an act of supreme hubris. Rather,
we concentrate ﬁrst on the epidemiology of changes in the mortality dis-
tribution and use that to suggest hypotheses about why they are occurring.
Even this is diﬃcult, though. Cause of death changes over time, as does
physician coding. It is not possible to put together an entirely consistent
mortality record over time. We present here what is most readily compa-
rable and save less comparable data for future analysis.
A ﬁrst way to approach the sources of mortality reduction is to look at
what causes of death declined most rapidly over time. Table 9.3 shows in-
formation on this. The rows of the table show the various causes of death.
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Table 9.2 Change in Mortality Rates, by Age (annual rate of decline for each
age group)
Age Groups 1900–1940 1940–1960 1960–1990
Total change (%) 0.9 1.5 1.2
Decline by age:
Infant mortality ( 1) 2.7 3.5 3.3
Child mortality (1–14) 4.2 4.4 2.5
Young adult mortality (15–44) 2.1 3.1 0.6
Older adult mortality (45–64) 0.6 1.4 1.3


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.The columns are the diﬀerent time periods. In each case, we report mor-
tality rates at the beginning of the sample and the annual change in mor-
tality rates attributable to that cause. We separate these changes into the
three time periods analyzed previously: 1900–40, 1940–60, and 1960–90.
Infectious diseases were the leading causes of death in 1900. Together,
infectious diseases accounted for 32 percent of total deaths. Pneumonia
and inﬂuenza were the biggest killers, accounting for 12 percent of total
deaths by themselves. Tuberculosis was also important, and to a lesser ex-
tent dysentery, enteritis, diarrheal diseases, and diseases where vaccina-
tions are today possible. The leading killers of today—cardiovascular dis-
ease and cancer—together accounted for fewer deaths than infectious
diseases in 1900.
Infectious diseases also saw the most rapid mortality declines in the
1900–40 period. Deaths from pneumonia and inﬂuenza fell by 2.4 percent
annually between 1900 and 1940. Deaths from tuberculosis and vaccine-
preventable illness both fell 3 to 6 percent annually. In total, reduced death
from infectious diseases accounts for three-quarters of total mortality re-
duction in this period. Figures 9.5, 9.6, and 9.7 show mortality from pneu-
monia and inﬂuenza, tuberculosis, and vaccine-amenable conditions
graphically. Death from all of these causes was falling markedly through-
out the time period.
The ﬁgures make another important point—most of the mortality re-
ductions for these conditions occurred well before the ﬁrst medical treat-
ment was available. Pneumonia and inﬂuenza are mostly treated with peni-
cillin, and before that with sulfa drugs. But sulfa drugs were discovered 
in 1935, and essentially all of the decline in pneumonia- and inﬂuenza-
attributable deaths occurred well before sulfa drugs were available. Tuber-
culosis mortality fell long before antituberculosis drugs came into use in
the mid-1940s. And vaccine-preventable deaths declined well before there
were vaccines.
We are by no means the ﬁrst to notice this ﬁnding. Thomas McKeown
(1976) and McKeown, Record, and Turner (1975) ﬁrst brought the issue to
prominence, and it has been a well-recognized fact ever since. Indeed, sub-
stantial research has been devoted to understanding why these diseases 
declined prior to the advent of eﬀective medical care. The two leading hy-
potheses are that nutritional improvements allowed people to avoid
contracting disease and withstand disease once it was contracted (Fogel
1994), and that public health measures reduced the spread of disease (Pres-
ton 1996). In each case, preventing disease among some people may limit
its spread among others as well. We do not have any additional evidence to
bring to bear on this issue. Rather, the focus of our analysis is on the tran-
sition from this period to later ones.
In contrast to infectious diseases, diseases of old age—cardiovascular
disease and cancer most prominently—were increasing over the 1900 to







































































































































































































































































































































































































































.1940 period, as ﬁgures 9.8 and 9.9 show. Cardiovascular disease mortality
increased by 0.9 percent annually from 1900 to 1940, and cancer mortality
increased by 1.2 percent annually. It is not completely known whether the
increase in cardiovascular disease mortality results from better diagnosis
or a true rise in cardiovascular deaths, but it is believed by most to be at
least partly a true increase. We know, for example, that smoking rates were
increasing over this time period and smoking is a leading risk factor for
cardiovascular disease and cancer. Thus, there are identiﬁable factors that
would lead to increased mortality for these conditions.
The net eﬀect is that cardiovascular disease accounted for 22 percent of
mortality in 1900 but 44 percent of deaths in 1940. Cancer accounted for 5
percent of total deaths in 1900 and 11 percent of deaths in 1940.
9.3 Midcentury: First Medical Advance
Even with the dramatic decline in mortality from infectious diseases be-
tween 1900 and 1940, infectious diseases were still prominent killers in
1940. Thirteen percent of deaths resulted from infectious disease in 1940,
more than cancer but far below the now dominant cardiovascular disease.
Infectious disease mortality continued its substantial decline in the
1940–60 time period. Between 1940 and 1960, deaths due to infectious dis-
ease declined 5.7 percent per year, well above the 3.2 percent annual rate
between 1900 and 1940. In total, the decline in infectious disease mortality
accounted for 34 percent of the total decline in mortality in this period.
What is diﬀerent about the decades in midcentury is the growing impor-
tance of medical care in this mortality decline. Midcentury saw the devel-
opment and widespread diﬀusion of drugs to treat many infectious dis-
eases, most importantly sulfa drugs and penicillin. These drugs are used
most prominently in treating pneumonia but also other infectious diseases
as well. Following the introduction of sulfa drugs and penicillin, mortality
for conditions where penicillin is eﬀective declined particularly rapidly. For
example, pneumonia and inﬂuenza deaths declined at an annual rate of 2.4
percent per year between 1900 and 1940, but by 3.9 percent per year be-
tween 1940 and 1960. As ﬁgure 9.5 shows, the timing of the more rapid
mortality reduction is coincident with the development of these medica-
tions. It is therefore a reasonable inference that medical innovation ex-
plains part of this more rapid decline.
We can be more formal about this conclusion. Because we believe that
much of the decline in pneumonia and inﬂuenza before 1940 stemmed
from better nutrition and public health measures, one way to more for-
mally test whether penicillin and sulfa drugs had a signiﬁcant impact on
these diseases is to compare pneumonia and inﬂuenza mortality to another
disease or set of diseases that are sensitive to public health and nutrition,
but not sensitive to penicillin or sulfa drugs. Dysentery, enteritis, and






































































































































































.diarrheal diseases provide such an example because these diseases are
largely viral and thus do not respond to antibiotics. Individuals with bet-
ter nutrition will be more resistant to these diseases, and better sanitation,
cleaner water supply, and better hygiene in general helps to prevent the
spread of these diseases.
Table 9.4shows a simple diﬀerence-in-diﬀerence calculation of the trend
in deaths due to these diseases during the twenty years before and twenty
years after the advent of sulfanomide drugs and penicillin. Deaths due to
dysentery, enteritis, and diarrheal diseases declined in both time periods
but much more rapidly during the 1915–35 time period than the 1945–65
time period. The slowdown in the rate of decline was 3.3 percent per year.
In contrast, deaths due to pneumonia and inﬂuenza witnessed a more
rapid decline during the postantibiotic period, by 0.5 percent per year. If
one believes that deaths due to these diseases would have experienced sim-
ilar declines in the absence of antibiotics, this diﬀerence-in-diﬀerence of
3.8 percent per year following antibiotics suggests that antibiotics did sig-
niﬁcantly impact mortality.
This conclusion also ﬁnds support in the literature. McDermott (1978)
noted the rapid decline in infectious disease mortality after 1937 and at-
tributed it to pharmaceutical advance as well.
Other important diseases declined signiﬁcantly midcentury, and med-
ical care plays a clear role in these cases as well. For example, chronic
nephritis accounted for 13 percent of deaths in 1940, but declined 4.7 per-
cent per year until 1960. This decline alone accounts for 32 percent of the
decline in total mortality. Figure 9.10 shows deaths from nephritis over
time. The decline in mortality from kidney disease is coincident with the
advent of kidney dialysis in the United States in 1948. While there was a
small decline in deaths from kidney disease in the late 1920s and 1930s, the
rate of mortality decline increased dramatically in the 1940s.
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Table 9.4 Diﬀerence-in-Diﬀerence of Eﬀect of Medications on Mortality (%)
Annual Change in Mortality
Before Sulfanomides After Sulfanomides
and Penicillin and Penicillin
Disease (1915–1935) (1945–1965) Diﬀerence
Pneumonia/inﬂuenza –1.9 –2.4 –0.5
Dysentery, enteritis, 
diarrheal disease –6.1 –2.8 3.3
Diﬀerence-in-diﬀerence –3.8



















































































.9.4 The Later Decades: Cardiovascular Disease 
and Low Birth Weight Infants
By 1960, infectious disease mortality was extremely low. The cumulative
decline in infectious disease deaths from 1900 to 1960 was 92 percent. And
even though infectious disease mortality continued to decline, further de-
clines did not contribute greatly to overall improvements in life expectancy
at birth. After all, even a large decline in mortality from a cause that does
not kill many people has little impact on overall longevity. The leading
killers in 1960 were cardiovascular disease (59 percent of the total) and
cancer (15 percent of the total). Infectious disease mortality was only 5
percent of total mortality.
It was around this time that mortality reductions as a whole slowed. Be-
tween 1955 and 1965, overall mortality was ﬂat. The already low level of in-
fectious disease mortality, combined with the lack of progress in mortality
from the chronic diseases of old age, was a leading reason for this. The re-
alization that the traditional killers had largely been eliminated led to pes-
simism about future improvements in longevity. It was feared that techno-
logical progress had done all for health that it was able to do and that the
limits of longevity had been reached. Famed biologist Rene Dubos was
among those who believed that “Modern medicine has little to oﬀer for the
prevention or treatment of chronic and degenerative diseases that domi-
nate the pathological picture of technologic societies” (Dubos 1969, 328).
Beginning in the mid-1960s, though, cardiovascular disease mortality
began to decline. The decline, shown in ﬁgure 9.8, was rapid, about 2 per-
cent per year through the end of the century. The cumulative decline in
cardiovascular disease mortality between 1960 and 1995 was close to two-
thirds.
Cardiovascular disease is most prominent among the elderly, so the mor-
tality gains were concentrated there. Indeed, cardiovascular disease is so
prominent among the elderly that the decline in cardiovascular disease
mortality explains essentially all of the overall reduction in mortality for
the elderly since 1965. For the population as a whole, 98 percent of mor-
tality reductions between 1960 and 1990 were a result of reduced cardio-
vascular disease mortality.
There are several causes of reduced cardiovascular disease mortality.
Cutler and Kadiyala (2001) document the sources and provide a rough at-
tribution. According to their ﬁndings, medical care accounts for a rela-
tively large share of cardiovascular disease mortality reduction. A major
component of such care is high-tech medical interventions for the treat-
ment of acute heart disease, particularly heart attacks. These interventions
include drugs to dissolve blood clots and restore blood ﬂow to the heart,
surgical procedures such as bypass surgery and angioplasty, and special-
ized equipment such as coronary care units and trained emergency re-
354 David M. Cutler and Ellen Mearasponse teams. A related component is low-tech medical care, largely phar-
maceuticals. Medications to reduce blood pressure, manage cholesterol,
control the heart rhythm, reduce the heart’s workload in times of stress,
and similar goals have reduced mortality for patients with heart disease
and prevented serious occurrences of heart disease for patients who have
not yet experienced a severe episode.
Cutler and Kadiyala (2001) also highlight the importance of behavioral
changes. Principal among these is the reduction in smoking. As ﬁgure 9.11
shows, smoking rates fell after 1960, after six decades of continuous in-
crease. Between 1960 and 1990, the number of cigarettes smoked declined
by one-third. Reductions in fat intake have also played a role in better
health.
This decomposition of mortality reductions for cardiovascular disease is
not as accurate as one would like. Issues such as changes in childhood dis-
ease and birth weight, which may aﬀect cardiovascular disease in later life,
are not explicitly accounted for. Still, even this rough decomposition of mor-
tality makes clear the growing medicalization of better health. A signiﬁcant
part of reduced mortality is directly attributable to medical interventions, ei-
ther for acute disease or in a chronic setting. Another large part is behav-
ioral, but has roots in medical knowledge about the origins of disease.
Indeed, the medicalization of mortality reduction extends even to ages
where medicine traditionally had a very small role. It was noted earlier, for
example, that infant mortality reductions contributed to improved life ex-
pectancy at birth in the 1960 to 1990 time period just as they did in the pre-
1960 time period. But the nature of these changes after 1960 was very dif-
ferent.
Figure 9.12 divides infant mortality into two components: neonatal
mortality, or death in the ﬁrst twenty-eight days of life; and postneonatal
mortality, or death in the subsequent eleven months. In the ﬁrst half of the
century, postneonatal mortality declines were substantially more impor-
tant than neonatal mortality declines. Between 1915 and 1960, postneona-
tal mortality declined by 4.4 percent per year, compared to a 1.9 percent
annual decline in neonatal mortality. Postneonatal mortality is generally
attributable to the infectious diseases noted previously, so this is consistent
with the aggregate evidence on mortality change.
Since 1960, however, most of the decline in infant mortality has been in
neonatal mortality. In the 1960 to 1998 period, neonatal mortality declined
by 3.5 percent annually, compared to 2.9 percent for postneonatal mortal-
ity. Death in the ﬁrst month of life is generally not a result of infectious dis-
ease. It is predominantly due to low birth weight and the adverse conse-
quences of low birth weight for infant development. In fact, our earlier
analysis of the issue (Cutler and Meara 2000) suggested that essentially all
of the reduction in neonatal mortality since 1960 can be attributed to med-
ical progress.






































































































































































































































.The decline in mortality in the latter part of the twentieth century there-
fore seems attributable in substantial measure to medical progress. That is
very diﬀerent from the reasons why mortality declined earlier in the cen-
tury and has enormous implications for the value of medical care.
9.5 Other Factors Inﬂuencing Mortality
Still, medicine is not the only factor inﬂuencing health. Understanding
mortality reductions requires us to disentangle many diﬀerent causes. We
discuss in this section several additional causes of mortality reduction and
some evidence on their importance. The logical next step—estimating how
important the diﬀerent factors are—we leave to future work.
9.5.1 Behavior
Some behaviors promote health and others worsen it. Behavioral change
is a key component of health changes. The most signiﬁcant behavioral
change of the twentieth century was the rise and decline of smoking. Fig-
ure 9.11 shows smoking trends over the century. From essentially no ciga-
rette consumption in 1900, per capita consumption of cigarettes rose to
over 4,000 per year in 1960, or over two packs per smoker per day. Since
then, cigarette consumption has declined to about 2,000 per year, a reduc-
tion of over 50 percent.
The most important health consequences of smoking are heart disease
and cancer, particularly cancer of the lung, thorax, and bronchus.2 The
trend in cardiovascular disease mortality was discussed above. The trend
in smoking-sensitive cancers is shown in ﬁgure 9.13. Trends in mortality
from both of these conditions mirror the change in smoking, with a ten- to
twenty-year lag.
9.5.2 Socioeconomic Status
Socioeconomic status may aﬀect health in several ways. Medical tech-
nology is expensive, and income increases have been instrumental in ﬁ-
nancing that care. Further, socioeconomic status is associated with better
behaviors. Better educated, and thus richer, people smoke less than less ed-
ucated people (at least currently—they used to smoke more), perhaps be-
cause they know more about the true risks of disease. Education has a
slightly stronger relationship to smoking than income, but this could be ei-
ther because education truly matters more or because education picks up
measures of permanent income not well captured by current income in
most surveys on smoking.
But there are other links as well. Richer people may demand better
358 David M. Cutler and Ellen Meara
2. While many cancers are attributable in some part to smoking, smoking accounts for the
































































































.health, just as there is an income elasticity to many goods. The link be-
tween behavior and education suggests such an eﬀect. Some direct evi-
dence on this question comes from looking at suicide rates, shown inﬁgure
9.14. Since 1930, suicide rates among the elderly have fallen by 56 percent,
while rates among teens have tripled. The decline in suicide among the eld-
erly is coincident with the large absolute increase in income for the elderly
stemming from transfer programs such as Social Security and the pro-
grams that preceded it. Following the introduction of formal Social Secu-
rity beneﬁts, beneﬁts rose rapidly over the period from 1950 until 1970,
with a particularly rapid rise in the late 1960s. During these same time pe-
riods, suicide rates among the elderly fell most rapidly. It is less clear that
the rise in youth suicide reﬂects falling income, although it may be due to
other social pressures that are inﬂuencing youths (Cutler, Glaeser, and
Norberg 2001).
Finally, income may aﬀect health in other, indirect ways. A large litera-
ture on income inequality and health ﬁnds a correlation between adverse
health outcomes and high levels of income inequality, even after control-
ling for mean income (Wilkinson 1996; Berkman and Kawachi, 2000). This
literature has been questioned as being not particularly robust (Mellor and
Milyo 2001) and as inconsistent with posited mechanisms for action
(Deaton 2001). Overall, therefore, it is diﬃcult to tell if this mechanism is
important in practice.
Some of the most compelling research on social status and health comes
from the Whitehall study of British civil servants (Marmot et al. 1984,
1987, 1991). In a series of studies following civil servants over time, it has
been well documented that professionals in the British civil service experi-
ence  better health than their counterparts in lower-level occupations
within the civil service. This is true for mortality and a variety of health
measures related to cardiovascular disease and other major morbidities. It
is also true for risk factors such as smoking, sedentary lifestyle, and related
behavioral variables, although these lifestyle factors cannot explain the
entire diﬀerence in health outcomes across occupation. As income gaps
widen over time, disparities in health have also widened (Menchik 1993).
9.5.3 Social Policies
Social policy is a third additional factor inﬂuencing mortality. Social
policy is a vast term, and it is helpful to disaggregate it. Some social poli-
cies are clearly oriented to health improvements. Medicare and Medicaid
are prime examples. Both programs were designed to increase access to
health care for vulnerable populations, the elderly, and the poor, with the
ultimate goal of improving health for these groups.
Other social policies such as Social Security aﬀect income and may
aﬀect health through that channel. Income may have direct eﬀects on
health by increasing the purchase of medical care services and ﬁnancing








































































.consumption of items such as nutritious food that contributes to good
health, or indirect eﬀects by increasing the desire for healthy behaviors to
enjoy a longer and higher quality life. It may be diﬃcult to measure the pre-
cise impact of Social Security beneﬁts on overall health, but evidence, such
as that presented on suicide in ﬁgure 9.14, suggests that income beneﬁts
can have a substantial impact on the well-being of the elderly.
Finally, some social policies may aﬀect health by changing the access
that people have to already-established resources. One example of such
policies would be the combination of civil rights legislation and improved
health programs for the poor during the mid-1960s, especially through
Medicaid. Ongoing work by Almond, Chay, and Greenstone (2001) sug-
gests that the Civil Rights Act, along with expansions in the Medicaid pro-
gram, led to substantial improvements in access to care, and ultimately in
health outcomes for the poor. They show this by comparing white and non-
white infant mortality disparities over time, presented in ﬁgure 9.15.
There is a clear decline in the ratio of nonwhite to white infant mortality
following the 1966 Civil Rights Act. However, the considerable change in
the nonwhite to white ratio of infant deaths over the century suggests that
there are many factors that inﬂuenced health diﬀerentially for the diﬀerent
races. For example, the period during World War II shows a big fall in the
ratio of nonwhite to white infant mortality. This shrinking infant mortal-
ity gap mirrors the shrinking racial wage gaps that occurred during World
War II. It is also interesting to note that the ratio of nonwhite to white in-
fant mortality is higher during the last decade of the century than at any
other point in the past 100 years.
9.6 Conclusion
Mortality has declined continuously in most developed countries over
the course of the twentieth century. In the United States, mortality rates de-
clined every decade, and with the exception of a single ten-year period, did
so at relatively constant rates.
But the constancy of mortality reductions masks signiﬁcant heterogene-
ity by age, cause, and source. Early in the twentieth century, mortality de-
clines resulted from public health and economic measures that improved
peoples’ ability to withstand disease. Formal medical care was unimpor-
tant for longer life. Because nutrition and public health were more impor-
tant for the young than the old, mortality reductions were concentrated at
younger ages. By midcentury, medical care became more signiﬁcant and
other factors less so. Penicillin and sulfa drugs brought the ﬁrst mortality
reductions at older ages, which were coupled with continuing improve-
ments in health at younger ages. The pattern of mortality reduction was
relatively equal by age.
In the latter part of the twentieth century, death became increasingly






































































































































































.medicalized. Cardiovascular disease mortality was prevented in signiﬁcant
part through medical intervention. Traditional killers such as pneumonia
in the young continued to decline, but mortality from these causes was al-
ready so low that further improvements did not add greatly to overall
longevity. Rather, infant mortality declined because medical advances kept
alive infants born of low birth weight. Still, there was a signiﬁcant shift in
the nature of longevity improvements away from improvements at younger
ages and toward improvements at older ages. Most of the additional years
added to life in the last few decades of the twentieth century were at older
ages.
Medical care is an important, but not the only important, factor in re-
duced mortality. In addition to nutrition and public health, health insur-
ance programs, income changes, and social policies more generally have all
contributed to longer life. Disentangling the role of these diﬀerent factors
in reduced mortality is a diﬃcult task but one that is increasingly impor-
tant in light of the vast ﬁscal consequences of an aging society.
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